Headache as the initial manifestation of neurocysticercosis: a case of eosinophilic meningitis.
Sohrabi
Farrokh
F
Anne Arundel Medical Center, Department of Medicine, Annapolis, MD, USA.
D000328:Adult; D015766:Albendazole / Q000627:therapeutic use; D000906:Antibodies / Q000097:blood / Q000134:cerebrospinal fluid; D001921:Brain / Q000000981:diagnostic imaging / Q000469:parasitology / Q000473:pathology; D002114:Calcinosis / Q000000981:diagnostic imaging / Q000469:parasitology / Q000473:pathology; D003907:Dexamethasone / Q000627:therapeutic use; D004802:Eosinophilia / Q000150:complications / Q000469:parasitology / Q000503:physiopathology; D006261:Headache / Q000150:complications / Q000469:parasitology* / Q000473:pathology; D006801:Humans; D007124:Immunoenzyme Techniques; D007958:Leukocyte Count; D008279:Magnetic Resonance Imaging; D008297:Male; D008582:Meningitis, Aseptic / Q000150:complications / Q000469:parasitology* / Q000473:pathology; D019547:Neck Pain / Q000209:etiology; D020019:Neurocysticercosis / Q000150:complications / Q000175:diagnosis* / Q000473:pathology; D010672:Phenytoin / Q000627:therapeutic use; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000906:Antibodies; D010672:Phenytoin; D003907:Dexamethasone; D015766:Albendazole